Company

Leadership

Marvin Fritzler. Professor of Autoimmune and inflammatory diseases

Dr. Marvin J. Fritzler

Dr. Marvin J. Fritzler, is the founder of MitogenDx and has served as its Director for over 40 years.  Dr. Fritzler is also Professor Emeritus at the University of Calgary, Cumming School of Medicine. Receiving his PhD in Cell Biology at the University of Calgary in 1971, after his MD in 1974 Dr. Fritzler continued with postdoctoral research in Autoimmunity at the Scripps Clinic and Research Institute in La Jolla, CA and at the University of Colorado in Denver. His areas of expertise include autoimmune diseases, cell and molecular biology of autoantigens, laboratory diagnostics, and policy and strategy for innovation. Under Dr. Fritzler’s leadership and driven by his passion for precision health, MitogenDx has gained international recognition and provides diagnostic services worldwide.

school icon

Education

  • Post-Doctoral: Autoimmunity (Scripps Clinic and Research Institute, La Jolla CA; University of Colorado, Denver CO)
  • PhD: Cell Biology (University of Calgary)
  • MD: Medicine (University of Calgary)
  • BSc: Zoology/Biology (University of Alberta)
consciousness icon

Areas of Expertise

  • Autoimmune Diseases
  • Environmental Medicine
  • Cell and Molecular Biology of Autoantigens
  • Precision Medicine
  • Laboratory Diagnostics
  • Strategy & Policy: Science, Research, Technology, Innovation
microscope

Key Member of Team Research

  • Canadian Scleroderma Research Group
  • Canadian Inflammatory Myopathy Study (CIMS)
  • UCAN-CANDU-CANCure: Canada–Netherlands Study of Juvenile Arthritis
  • Tri-Nation (Canada, USA, Australia) Scleroderma Research Group
  • LEAPPS: Longitudinal Examination of ANA Prevalence, Predictors and Performance in SLE

Dr. May Y. Choi

Dr. May Choi is the Associate Director of MitogenDx, bringing extensive expertise in autoimmune diseases and innovative diagnostics. She completed her MD at the University of Alberta and training in Internal Medicine and Rheumatology at the University of Calgary. Dr. Choi holds a Master of Public Health in Epidemiology from Harvard University and completed a clinical and research lupus fellowship at Brigham and Women’s Hospital, Harvard Medical School. Her areas of expertise include systemic lupus erythematosus, biomarker discovery, precision medicine, and the application of artificial intelligence in laboratory diagnostics. Dr. Choi’s leadership at MitogenDx supports the company’s mission to deliver advanced autoimmune diagnostic services on local, national, and international scales.

school icon

Education

  • Lupus Fellowship: Clinical and Research Lupus Fellowship (Brigham and Women’s Hospital, Harvard Medical School)
  • Graduate: Master of Public Health, Epidemiology (Harvard University)
  • MD: Medicine (University of Alberta)
  • BHSc: Biomedical Sciences, Honours (University of Calgary)
consciousness icon

Areas of Expertise

  • Autoimmune Diseases
  • Lupus (Systemic Lupus Erythematosus)
  • Biomarker Discovery and Autoantibody Profiling
  • Precision Medicine
  • Artificial Intelligence & Machine Learning in Diagnostics
  • Epidemiology & Public Health
  • Translational Research and Biobanking
  • Laboratory Diagnostics
microscope

Key Member of Team Research

  • Canadian Scleroderma Research Group (CSRG)
  • Lupus Study Group
  • Arthritis Research Canada
  • CanRIO: The Canadian Research Group of Rheumatology in Immuno-Oncology
  • CaNIOS: The Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus